Author:
Zhou Guoliang,Qin Meisong,Zhang Xiaolin,Yang Jianting,Yu Hao
Reference20 articles.
1. Topoisomerase I inhibitors: camptothecins and beyond;Pommier;Nat Rev Cancer,2006
2. Topotecan in combination with cisplatin for the treatment of stage IVB, recurrent, or persistent cervical cancer;Brave;Oncology (Williston Park, NY),2006
3. A phase I/II study of CY and topotecan in patients with high-risk malignancies undergoing autologous hematopoietic cell transplantation: the St Jude long-term follow-up;Kasow;Bone Marrow Transplant,2012
4. Topotecan, thiotepa, and carboplatin for neuroblastoma: failure to prevent relapse in the central nervous system;Kushner;Bone Marrow Transplant,2006
5. Phase I and pharmacokinetic study of topotecan administered orally once daily for 5 days for 2 consecutive weeks to pediatric patients with refractory solid tumors;Daw;J Clin Oncol,2004